questionsmedicales.fr
Troubles mentaux
Troubles du contrôle des impulsions
Troubles du contrôle des impulsions : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles du contrôle des impulsions : Questions médicales les plus fréquentes",
"headline": "Troubles du contrôle des impulsions : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles du contrôle des impulsions : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-17",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles du contrôle des impulsions"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles mentaux",
"url": "https://questionsmedicales.fr/mesh/D001523",
"about": {
"@type": "MedicalCondition",
"name": "Troubles mentaux",
"code": {
"@type": "MedicalCode",
"code": "D001523",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pyromanie",
"alternateName": "Firesetting Behavior",
"url": "https://questionsmedicales.fr/mesh/D005391",
"about": {
"@type": "MedicalCondition",
"name": "Pyromanie",
"code": {
"@type": "MedicalCode",
"code": "D005391",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.250.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Jeu de hasard",
"alternateName": "Gambling",
"url": "https://questionsmedicales.fr/mesh/D005715",
"about": {
"@type": "MedicalCondition",
"name": "Jeu de hasard",
"code": {
"@type": "MedicalCode",
"code": "D005715",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.250.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trichotillomanie",
"alternateName": "Trichotillomania",
"url": "https://questionsmedicales.fr/mesh/D014256",
"about": {
"@type": "MedicalCondition",
"name": "Trichotillomanie",
"code": {
"@type": "MedicalCode",
"code": "D014256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.250.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles du contrôle des impulsions",
"alternateName": "Disruptive, Impulse Control, and Conduct Disorders",
"code": {
"@type": "MedicalCode",
"code": "D007174",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "23andMe, Sunnyvale, California, USA."
}
},
{
"@type": "Person",
"name": "Ana Marques",
"url": "https://questionsmedicales.fr/author/Ana%20Marques",
"affiliation": {
"@type": "Organization",
"name": "EA 7280 Laboratory of Neuropychopharmacology of the Subcortical Dopaminergic Systems, UFR Medecine, Université Clermont Auvergne, Clermont-Ferrand, France."
}
},
{
"@type": "Person",
"name": "Pedro M Paz-Alonso",
"url": "https://questionsmedicales.fr/author/Pedro%20M%20Paz-Alonso",
"affiliation": {
"@type": "Organization",
"name": "Basque Center on Cognition, Brain and Language (BCBL), San Sebastián, Spain. Electronic address: p.pazalonso@bcbl.eu."
}
},
{
"@type": "Person",
"name": "Manuel Delgado-Alvarado",
"url": "https://questionsmedicales.fr/author/Manuel%20Delgado-Alvarado",
"affiliation": {
"@type": "Organization",
"name": "Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain; Neurology Department, Sierrallana Hospital, Torrelavega, Spain; IDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain; Biomedical Research Networking Center for Mental Health (CIBERSAM), Madrid, Spain. Electronic address: manueldelgadoalv@gmail.com."
}
},
{
"@type": "Person",
"name": "Maria Livia Fantini",
"url": "https://questionsmedicales.fr/author/Maria%20Livia%20Fantini",
"affiliation": {
"@type": "Organization",
"name": "EA 7280 Laboratory of Neuropychopharmacology of the Subcortical Dopaminergic Systems, UFR Medecine, Université Clermont Auvergne, Clermont-Ferrand, France. mfantini@chu-clermontferrand.fr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Progressive Paracentral Visual Field Loss at Low Intraocular Pressures Following LASIK.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/39141409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002395"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human perception of spatial frequency varies with stimulus orientation and location in the visual field.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37848541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-44673-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cortical magnification eliminates differences in contrast sensitivity across but not around the visual field.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/36961485",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.84205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35939832",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002092"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insights into the relationship between eye movements and personality traits in restricted visual fields.",
"datePublished": "2024-05-04",
"url": "https://questionsmedicales.fr/article/38704441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-60992-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles du contrôle des impulsions",
"item": "https://questionsmedicales.fr/mesh/D007174"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles du contrôle des impulsions - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles du contrôle des impulsions",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles du contrôle des impulsions",
"description": "Comment diagnostique-t-on un trouble du contrôle des impulsions ?\nQuels critères sont utilisés pour le diagnostic ?\nLes tests psychologiques sont-ils nécessaires ?\nQui peut poser le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles du contrôle des impulsions",
"description": "Quels sont les symptômes courants des troubles du contrôle des impulsions ?\nComment se manifeste l'impulsivité ?\nY a-t-il des signes d'alerte précoce ?\nLes troubles de l'humeur sont-ils liés ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles du contrôle des impulsions",
"description": "Peut-on prévenir les troubles du contrôle des impulsions ?\nQuel rôle joue l'éducation dans la prévention ?\nLes programmes de sensibilisation sont-ils efficaces ?\nComment les parents peuvent-ils aider ?\nLe soutien scolaire joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles du contrôle des impulsions",
"description": "Quels traitements sont disponibles pour ces troubles ?\nLa thérapie cognitive est-elle efficace ?\nLes médicaments peuvent-ils aider ?\nLa thérapie de groupe est-elle bénéfique ?\nCombien de temps dure le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles du contrôle des impulsions",
"description": "Quelles complications peuvent survenir ?\nLes troubles de l'humeur sont-ils des complications possibles ?\nComment les comportements à risque affectent-ils la vie ?\nLes relations sociales sont-elles affectées ?\nY a-t-il un risque accru de toxicomanie ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles du contrôle des impulsions",
"description": "Quels sont les facteurs de risque principaux ?\nLe stress peut-il aggraver ces troubles ?\nL'environnement familial joue-t-il un rôle ?\nLes troubles de l'attention sont-ils un facteur de risque ?\nL'âge d'apparition influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un trouble du contrôle des impulsions ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique des symptômes et l'historique du patient."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des comportements impulsifs récurrents et des conséquences négatives."
}
},
{
"@type": "Question",
"name": "Les tests psychologiques sont-ils nécessaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être utilisés pour évaluer la gravité des symptômes et l'impact fonctionnel."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychiatre ou un psychologue qualifié peut poser le diagnostic après évaluation."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux de troubles mentaux peuvent être un facteur de risque."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles du contrôle des impulsions ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'agressivité, l'irritabilité et des comportements destructeurs."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'impulsivité ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impulsivité se manifeste par des actions sans réflexion préalable, souvent regrettées après."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte précoce ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des accès de colère fréquents ou des comportements à risque peuvent alerter."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'humeur peuvent coexister avec des troubles du contrôle des impulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et du développement psychologique."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles du contrôle des impulsions ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est possible par l'éducation et le soutien émotionnel dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation aide à développer des compétences de gestion des émotions et des comportements."
}
},
{
"@type": "Question",
"name": "Les programmes de sensibilisation sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes de sensibilisation peuvent réduire les comportements à risque chez les jeunes."
}
},
{
"@type": "Question",
"name": "Comment les parents peuvent-ils aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent aider en établissant des règles claires et en offrant un soutien affectif."
}
},
{
"@type": "Question",
"name": "Le soutien scolaire joue-t-il un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un soutien scolaire adéquat peut aider à prévenir les comportements impulsifs chez les enfants."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces troubles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale et, parfois, des médicaments."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cognitive aide à modifier les pensées et comportements impulsifs."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les antidépresseurs peuvent être prescrits pour réduire les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie de groupe offre un soutien et des stratégies de gestion des impulsions."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité des symptômes et la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes relationnels, juridiques et des troubles associés."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils des complications possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'humeur comme la dépression peuvent survenir en raison de l'impulsivité."
}
},
{
"@type": "Question",
"name": "Comment les comportements à risque affectent-ils la vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque peuvent entraîner des blessures, des problèmes juridiques et des regrets."
}
},
{
"@type": "Question",
"name": "Les relations sociales sont-elles affectées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du contrôle des impulsions peuvent nuire aux relations interpersonnelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de toxicomanie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec ces troubles peuvent avoir un risque accru de développer des addictions."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des traumatismes et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver ces troubles ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes des troubles du contrôle des impulsions."
}
},
{
"@type": "Question",
"name": "L'environnement familial joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable peut augmenter le risque de développer ces troubles."
}
},
{
"@type": "Question",
"name": "Les troubles de l'attention sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'attention peuvent coexister et augmenter le risque d'impulsivité."
}
},
{
"@type": "Question",
"name": "L'âge d'apparition influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une apparition précoce des symptômes peut indiquer un risque accru de complications."
}
}
]
}
]
}
Intraocular pressure is currently the only known reliable, modifiable risk factor for the development and progression of glaucoma. Other risk factors for glaucoma include increasing age, myopia, decre...
Neuroanatomical variations across the visual field of human observers go along with corresponding variations of the perceived coarseness of visual stimuli. Here we show that horizontal gratings are pe...
Human visual performance changes dramatically both across (eccentricity) and around (polar angle) the visual field. Performance is better at the fovea, decreases with eccentricity, and is better along...
The earlier a person quits smoking the more likely is the optic nerve be spared from damage....
To investigate the effect of smoking cessation on visual field (VF) progression in glaucoma....
Primary open angle glaucoma patients with a minimum of 3 years follow-up and 5 VFs were included. Linear mixed models were used to investigate the effects of smoking on the rates of 24-2 VF mean devia...
Five hundred eleven eyes of 354 patients were included over the mean follow-up of 12.4 years. Mean baseline age (95% confidence interval) was 62.3 (61.2, 63.4) years. One hundred forty nine (42.1%) pa...
After ≥25 years of smoking cessation, the risk of VF progression in former heavy smokers becomes similar to never smokers. Long-term smoking cessation may be associated with lower VF progression in gl...
Previous studies have suggested behavioral patterns, such as visual attention and eye movements, relate to individual personality traits. However, these studies mainly focused on free visual tasks, an...
Despite, the potential clinical utility of 60-4 visual fields, they are not frequently used in clinical practice partly, due to the purported impact of facial contour on field defects. The purpose of ...
Subjects with no ocular pathology were included. Participants were subject to optical coherence tomography, 60-4 Swedish interactive thresholding algorithm visual field tests and photography. The pred...
30 healthy were enrolled. Three-dimensional facial reconstruction using a convolution neural network (CNN) was able to predict facial contour-dependent 60-4 visual field defects in 30 subjects without...
This pilot study reports the development of a CNN-enhanced platform capable of predicting 60-4 visual field defects in healthy controls based on facial contour. Further study with this platform may en...
To measure visual field (VF) rates of change after Ahmed Glaucoma Valve (AGV) implantation and to investigate risk factors for progression....
Retrospective, clinical cohort study....
Patients who underwent AGV implantation with at least 4 eligible postoperative VFs and 2 years of follow-up were included. Baseline, intraoperative, and postoperative data were collected. VF progressi...
A total of 173 eyes were included. The intraocular pressure (IOP) and number of glaucoma medications were significantly reduced from a median (interquartile range [IQR]) of 23.5 (12.1) mm Hg at baseli...
To our knowledge, this is the largest published series reporting long-term VF outcomes after glaucoma drainage device implantation. There is a continued, significant rate of VF decline after AGV surge...
To evaluate the relationship between interocular asymmetries of corneal hysteresis (CH) and visual field defects in Korean patients with glaucoma....
A total of 444 eyes from 222 participants with glaucoma in at least one eye were enrolled. CH was measured using an ocular response analyzer (Reichert Technologies Inc). Eyes of each participant were ...
Median (interquartile range) MD value was -3.71 dB (-6.87 to -1.30 dB) in the better eye and -10.20 dB (-16.32 to -5.62 dB) in the worse eye. When the correlation between the asymmetry of the MD value...
The interocular asymmetry of CH was significantly correlated with the interocular asymmetry of visual field defects in glaucoma....
To compare the accuracy of detecting moderate and rapid rates of glaucoma worsening over a 2-year period with different numbers of OCT scans and visual field (VF) tests in a large sample of glaucoma a...
Descriptive and simulation study....
The OCT sample comprised 12 150 eyes from 7392 adults with glaucoma or glaucoma suspect status followed up at the Wilmer Eye Institute from 2013 through 2021. The VF sample comprised 20 583 eyes from ...
Within-eye rates of change in retinal nerve fiber layer (RNFL) thickness and mean deviation (MD) were measured using linear regression. For each measured rate, simulated measurements of RNFL thickness...
The accuracy of diagnosing moderate and rapid rates of glaucoma worsening for different numbers of OCT scans and VF tests over a 2-year period....
Accuracy was less than 50% for both OCT and VF when diagnosing worsening after a 2-year period. OCT accuracy was 5 to 10 percentage points higher than VF accuracy at detecting moderate worsening and 1...
More frequent OCT scans and VF tests are needed to improve the accuracy of diagnosing glaucoma worsening. Accuracy greatly increases when relying on both OCT and VF to detect worsening....
The author(s) have no proprietary or commercial interest in any materials discussed in this article....
to compare visual field (VF) progression between the 2 arms of the Treatment of Advanced Glaucoma Study (TAGS)....
Post hoc analysis of VF data from a 2-arm, multicenter, randomized controlled clinical trial....
A total of 453 patients with newly diagnosed advanced open-angle glaucoma in at least 1 eye from 27 centers in the United Kingdom were randomized to either trabeculectomy (n = 227) or medication in th...
This study analyzed 211 eyes in the trabeculectomy first arm and 203 eyes in the medication first arm. The average RoP (estimate [95% credible intervals]) was -0.59 [-0.88, -0.31] dB/year in the medic...
There was no significant difference in the average RoP at 2 years....